“…Since their discovery in 2003 ( 1 ), G protein–coupled receptor (GPCR) proton sensors have been implicated in a variety of biological processes and disorders ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 ), including ischemia ( 11 , 12 , 13 ), inflammation ( 14 , 15 , 16 ), and signaling in tumor microenvironments ( 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ). The acidotic cues generated by these processes are known to stimulate GPCR signaling thought to contribute to a variety of cellular responses, such as fibroblast proliferation in cancer and insulin secretion ( 19 , 27 ).…”